Ligand validation:6DXP

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 6DXP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DXP_FMN_D_301	79%	31%	0.117	0.962	1.52	1.36	4	6	1	0	100%	1
6DXP_FMN_A_301	77%	30%	0.122	0.963	1.37	1.53	4	11	1	0	100%	1
6DXP_FMN_B_301	71%	29%	0.13	0.95	1.53	1.42	4	8	2	0	100%	1
6DXP_FMN_C_301	68%	29%	0.128	0.939	1.5	1.45	4	11	1	0	100%	1
8H4J_FMN_D_301	94%	60%	0.083	0.981	0.78	0.72	1	-	0	0	100%	1
7N2W_FMN_A_301	64%	43%	0.155	0.956	1.08	1.18	2	7	0	0	100%	1
4UTJ_FMN_A_1362	100%	48%	0.043	0.994	1.13	0.89	3	2	0	0	100%	1
6R2P_FMN_A_601	100%	28%	0.042	0.99	1.72	1.32	7	7	0	0	100%	1
7PGX_FMN_AAA_618	100%	62%	0.042	0.99	0.77	0.68	1	-	0	0	100%	1
4K8E_FMN_A_401	100%	46%	0.044	0.992	1.05	1.08	2	3	0	0	100%	1
4B5N_FMN_A_400	100%	53%	0.047	0.994	0.93	0.9	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.